CXCR4 and neoplasm: However, treatment with the Wnt inhibitor XAV939 (p = 0.0008) and the CXCR4 inhibitor AMD3100 (p = 0.0117) significantly reduced tumor weight in the CAF–PCSC co-implantation group (Figure 5A).